Vernal Keratoconjunctivitis: A Systematic Review

[1]  N. Papadopoulos,et al.  Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab , 2023, The World Allergy Organization journal.

[2]  N. Ebihara,et al.  Galectin-3, a damage-associated molecular pattern, in tears of patients with vernal keratoconjunctivitis , 2023, Japanese Journal of Ophthalmology.

[3]  C. Traverso,et al.  Clinical Outcomes of Topical 0.1% Ciclosporin Cationic Emulsion Used on Label in Children with Vernal Keratoconjunctivitis , 2023, Ophthalmology and Therapy.

[4]  H. Gobeka,et al.  Corneal topometric indices and proclivity toward corneal ectasia in vernal keratoconjunctivitis. , 2023, Journal francais d'ophtalmologie.

[5]  Song-lin Yang,et al.  Characteristics of Vernal Keratoconjunctivitis in Lhasa: A Single-Center, Observational Study. , 2023, Ocular immunology and inflammation.

[6]  A. Fiocchi,et al.  Vernal keratoconjunctivitis in Down syndrome: a case report , 2023, BMC Ophthalmology.

[7]  S. Heegaard,et al.  Novel Insights in the Management of Vernal Keratoconjunctivitis (VKC): European Expert Consensus Using a Modified Nominal Group Technique , 2023, Ophthalmology and Therapy.

[8]  K. Mashige,et al.  Diagnosis and management of keratoconus by eye care practitioners in Kenya , 2023, BMC Ophthalmology.

[9]  Dharshana Thiagarajan,et al.  Clinical Study on Corneal Topographical Changes in Vernal Keratoconjunctivitis by Using OCULUS Pentacam® , 2023, Cureus.

[10]  R. Kumari,et al.  Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus ointment in children with vernal keratoconjunctivitis , 2023, Therapeutic advances in ophthalmology.

[11]  Yujing Yang,et al.  Corneal biomechanical properties in vernal keratoconjunctivitis and its subtypes: a preliminary study , 2022, International Ophthalmology.

[12]  Arti Singh,et al.  Demographic and clinical characteristics of childhood and adult onset Vernal Keratoconjunctivitis in a tertiary care center during Covid pandemic: A prospective study , 2022, Romanian journal of ophthalmology.

[13]  Heba A El Gendy,et al.  Evaluation of corneal epithelial thickness mapping using anterior segment OCT in children with vernal keratoconjunctivitis , 2022, International Ophthalmology.

[14]  Y. Araki,et al.  Role of Oncostatin M in the Pathogenesis of Vernal Keratoconjunctivitis: Focus on the Barrier Function of the Epithelium and Interleukin-33 Production by Fibroblasts , 2022, Investigative ophthalmology & visual science.

[15]  Savitri Sharma,et al.  Tissue remodeling in adult vernal keratoconjunctivitis. , 2022, Experimental eye research.

[16]  Ken Fukuda,et al.  Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye. , 2022, Allergology international : official journal of the Japanese Society of Allergology.

[17]  A. Fukushima,et al.  A Case of Vernal Keratoconjunctivitis With Growth Hormone Deficiency , 2022, Cureus.

[18]  P. Vashist,et al.  Ocular surface characteristics in pediatric vernal keratoconjunctivitis: a clinico-cytological study. , 2022, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[19]  P. Asbell,et al.  Emerging therapies targeting eosinophil-mediated inflammation in chronic allergic conjunctivitis. , 2022, The ocular surface.

[20]  J. Mehta,et al.  Diagnosis, Management, and Treatment of Vernal Keratoconjunctivitis in Asia: Recommendations From the Management of Vernal Keratoconjunctivitis in Asia Expert Working Group , 2022, Frontiers in Medicine.

[21]  A. Fukushima,et al.  Effects of Antihistamine-Releasing Contact Lenses on Severe Allergic Conjunctivitis , 2022, Ocular immunology and inflammation.

[22]  F. Cavarzeran,et al.  Efficacy and Satisfaction of Cyclosporine 0.1% in Patients with Vernal Keratoconjunctivitis. , 2022, Ocular immunology and inflammation.

[23]  B. Chiang,et al.  Successful treatment and prevention of the recurrence of refractory vernal keratoconjunctivitis with dupilumab , 2022, Clinical & experimental ophthalmology.

[24]  Y. Subhi,et al.  Prevalence of allergic sensitization with vernal keratoconjunctivitis: A systematic review with meta‐analyses , 2022, Acta ophthalmologica.

[25]  A. Dahlmann-Noor,et al.  Management of Vernal Keratoconjunctivitis in Children in the United Kingdom: A Review of the Literature and Current Best Practice Across Six Large United Kingdom Centers. , 2022, Journal of pediatric ophthalmology and strabismus.

[26]  Z. Nagy,et al.  Examination of corneal microstructure in the quiescent phase of vernal keratoconjunctivitis using in vivo confocal microscopy , 2022, European journal of ophthalmology.

[27]  I. Shatriah,et al.  MicroRNA Profiling of the Tears of Children With Vernal Keratoconjunctivitis , 2022, Frontiers in Genetics.

[28]  P. Asbell,et al.  Lirentelimab for Severe and Chronic Forms of Allergic Conjunctivitis. , 2022, The Journal of allergy and clinical immunology.

[29]  N. Jain,et al.  Conjunctival Autograft for Bilateral Tarsal Keratinization in a Case of Chronic Vernal Keratoconjunctivitis , 2022, Cureus.

[30]  N. Jain,et al.  Allogeneic simple limbal epithelial transplantation for bilateral limbal stem cell deficiency in chronic vernal keratoconjunctivitis: A case report , 2022, International journal of surgery case reports.

[31]  En-Jie Shih,et al.  Treating refractory corneal hydrops in a male patient with vernal keratoconjunctivitis and mental retardation: a case report , 2022, BMC Ophthalmology.

[32]  J. Mehta,et al.  Long Term Outcomes of Surgical Excision of Giant Papillae with Mitomycin C and Amniotic Membrane Transplantation in the Treatment of Refractory Palpebral Vernal Keratoconjunctivitis , 2021, Medicina.

[33]  Leping Ye,et al.  Pediatric usage of Omalizumab: A promising one , 2021, The World Allergy Organization journal.

[34]  A. Fiocchi,et al.  The effect of COVID-19 imposed lockdown on Italian children with Vernal Keratoconjunctivitis , 2021, World Allergy Organization Journal.

[35]  A. Leonardi,et al.  Epithelial barrier dysfunction in ocular allergy , 2021, Allergy.

[36]  N. Eter,et al.  Treating Severe Pediatric Keratoconjunctivitis with Topical Cyclosporine A. , 2021, Klinische Monatsblatter fur Augenheilkunde.

[37]  T. Velpandian,et al.  Ocular surface sphingolipids associate with the refractory nature of vernal keratoconjunctivitis: newer insights in VKC pathogenesis , 2021, British Journal of Ophthalmology.

[38]  A. Lambiase,et al.  Vernal keratoconjunctivitis activity induces decrease of ocular surface CD14, TLR-4 and TLR-9 expression , 2021, European journal of ophthalmology.

[39]  Léon Muamba Nkashama,et al.  Sensitization and Clinical Characteristics of Congolese Children with Vernal Keratoconjunctivitis in Kinshasa , 2021, Ocular immunology and inflammation.

[40]  M. Sacchetti,et al.  Understanding Vernal Keratoconjunctivitis: Beyond Allergic Mechanisms , 2021, Life.

[41]  Yan Wang,et al.  Combination of 0.05% Azelastine and 0.1% Tacrolimus Eye Drops in Children With Vernal Keratoconjunctivitis: A Prospective Study , 2021, Frontiers in Medicine.

[42]  A. Zicari,et al.  Impact of screen exposure on pediatric vernal Keratoconjunctivitis: a survey during the COVID-19 pandemic in Italy , 2021, Italian Journal of Pediatrics.

[43]  M. Heikal,et al.  A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis , 2021, Graefe's Archive for Clinical and Experimental Ophthalmology.

[44]  A. Sharabi‐Nov,et al.  When to start tacrolimus ointment for vernal keratoconjunctivitis? A proposed treatment protocol , 2021, International Ophthalmology.

[45]  Bisant A. Labib,et al.  Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives , 2021, Pharmaceuticals.

[46]  Muawyah D. Al Bdour,et al.  Environmental Risk Factors Associated With the Need for Penetrating Keratoplasty in Patients With Keratoconus , 2021, Cureus.

[47]  Yizhi Liu,et al.  Association of Allergic Conjunctivitis With Health-Related Quality of Life in Children and Their Parents. , 2021, JAMA ophthalmology.

[48]  Rahul Singh,et al.  Knowledge, Awareness, and Practice Among Caregivers of Children With Vernal Keratoconjunctivitis in a Tertiary Care Pediatric Hospital. , 2021, Journal of pediatric ophthalmology and strabismus.

[49]  Kayli Fisher,et al.  Understanding the Journey of Patients With Vernal Keratoconjunctivitis: A Qualitative Study of the Impact on Children and Families. , 2021, Journal of pediatric ophthalmology and strabismus.

[50]  S. Yamagami,et al.  Alterations in Mucin-Associated Gene Expression on the Ocular Surface in Active and Stable Stages of Atopic and Vernal Keratoconjunctivitis , 2021, Journal of ophthalmology.

[51]  G. Marseglia,et al.  Vernal keratoconjunctivitis: An update , 2021, European journal of ophthalmology.

[52]  A. Fiocchi,et al.  Health‐related quality of life in children at the diagnosis of Vernal Keratoconjunctivitis , 2021, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[53]  L. Sousa,et al.  Vernal Keratoconjunctivitis as the Only Clinical Manifestation of HIV Infection , 2021, Ocular immunology and inflammation.

[54]  J. Baker,et al.  Efficacy of medical treatments for vernal keratoconjunctivitis: a systematic review and meta-analysis. , 2021, The Journal of allergy and clinical immunology.

[55]  S. Heegaard,et al.  Comparative efficacy of medical treatments for vernal keratoconjunctivitis in children and young adults: a systematic review with network meta‐analyses , 2021, Acta ophthalmologica.

[56]  A. Jain,et al.  Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus , 2021, Ocular immunology and inflammation.

[57]  Muhammet Derda Ozer,et al.  Corneal and lens densitometry in patients with vernal keratoconjunctivitis , 2021, International Ophthalmology.

[58]  P. Vishwakarma,et al.  Comparative profile of ocular surface microbiome in vernal keratoconjunctivitis patients and healthy subjects , 2021, Graefe's Archive for Clinical and Experimental Ophthalmology.

[59]  S. Koca,et al.  Giant Papilla Prolapse from the Upper Tarsal Conjunctiva in a 3-year-old Child: A Case Presentation and a Brief Literature Review , 2021, Beyoglu eye journal.

[60]  H. Fujishima,et al.  Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases , 2021, Allergy, Asthma & Clinical Immunology.

[61]  A. Murakami,et al.  Role of oncostatin M in the pathogenesis of vernal keratoconjunctivitis: focus on tissue remodeling , 2021, Japanese Journal of Ophthalmology.

[62]  S. Feizi,et al.  Comparison of penetrating keratoplasty and deep anterior lamellar keratoplasty in keratoconus eyes with vernal keratoconjunctivitis , 2021, Therapeutic advances in ophthalmology.

[63]  R. Sorkhabi,et al.  Serum vitamin D levels in patients with vernal keratoconjunctivitis and its relationship with disease severity , 2020, European journal of ophthalmology.

[64]  M. Duse,et al.  Is oxidative stress involved in vernal keratoconjunctivitis? Results from a pilot study in children , 2020, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[65]  A. Kheirkhah,et al.  Management of corneal complications in vernal keratoconjunctivitis: A review. , 2020, The ocular surface.

[66]  M. Docquier,et al.  Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis. , 2020, The ocular surface.

[67]  A. Messina,et al.  Tear N‐glycomics in vernal and atopic keratoconjunctivitis , 2020, Allergy.

[68]  Lai Jiang,et al.  Recognition of Atopic Keratoconjunctivitis During Treatment with Dupilumab for Atopic Dermatitis. , 2020, Journal of the American Academy of Dermatology.

[69]  Mehtap Çağlayan,et al.  Corneal and lens densitometry with Pentacam HR in children with vernal keratoconjunctivitis. , 2020, Clinical & experimental optometry.

[70]  M. El‐Agha,et al.  The prevalence of keratoconus in children with allergic eye disease in an Egyptian population , 2020, European journal of ophthalmology.

[71]  Elcio Luiz Bonamigo,et al.  Surgical debridement of corneal shield ulcers in pediatric patients: two case reports and a review of the literature , 2020, Journal of Medical Case Reports.

[72]  J. Shoji.  Ocular allergy test and biomarkers on the ocular surface: Clinical test for evaluating the ocular surface condition in allergic conjunctival diseases. , 2020, Allergology international : official journal of the Japanese Society of Allergology.

[73]  N. Sharma,et al.  Role of combined immunomodulator therapy in severe steroid intolerant vernal keratoconjunctivitis , 2020, Eye.

[74]  D. Bremond-Gignac,et al.  Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score , 2020, Journal of market access & health policy.

[75]  P. Marchisio,et al.  Role of ocular cytology in vernal keratoconjunctivitis , 2019, Immunity, inflammation and disease.

[76]  J. Németh,et al.  12-Month Results of Cyclosporine A Cationic Emulsion in a Randomized, Study in Patients With Pediatric Vernal Keratoconjunctivitis. , 2019, American journal of ophthalmology.

[77]  N. Rosário,et al.  ICON: Diagnosis and Management of Allergic Conjunctivitis. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[78]  Omar M Said,et al.  Standard cross‐linking protocol versus accelerated and transepithelial cross‐linking protocols for treatment of paediatric keratoconus: a 2‐year comparative study , 2019, Acta ophthalmologica.

[79]  I. Bahar,et al.  Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment , 2019, British Journal of Ophthalmology.

[80]  L. Delgado,et al.  Management of ocular allergy , 2019, Allergy.

[81]  J. Fauquert.  Diagnosing and managing allergic conjunctivitis in childhood: The allergist’s perspective , 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[82]  Ashik Mohamed,et al.  Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis , 2019, British Journal of Ophthalmology.

[83]  D. Edward,et al.  Rosai-Dorfman disease: Isolated epibulbar mass in patient with vernal keratoconjunctivitis , 2019, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.

[84]  Deepali Singhal,et al.  Vernal Keratoconjunctivitis. , 2019, Survey of ophthalmology.

[85]  J. Németh,et al.  A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study. , 2019, Ophthalmology.

[86]  A. Alemayehu,et al.  Prevalence of vernal keratoconjunctivitis and its associated factors among children in Gambella town, southwest Ethiopia, June 2018 , 2019, PloS one.

[87]  E. Takamura,et al.  Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis , 2019, Current eye research.

[88]  Sandra Flavia Fiorentini,et al.  Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East , 2019, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.

[89]  S. Mertens,et al.  SANRA—a scale for the quality assessment of narrative review articles , 2019, Research Integrity and Peer Review.

[90]  I. Wang,et al.  Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis , 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.

[91]  M. Ravindran,et al.  Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population. , 2019, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[92]  G. G. Müller,et al.  Long-term use of topical tacrolimus ointment: a safe and effective option for the treatment of vernal keratoconjunctivitis. , 2019, Arquivos brasileiros de oftalmologia.

[93]  S. Gandini,et al.  Vitamin D serum levels in children with vernal keratoconjunctivitis and disease control , 2019, International journal of immunopathology and pharmacology.

[94]  Jason K. Lee,et al.  Omalizumab as single-dose therapy for vernal keratoconjunctivitis. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[95]  L. Borrego-Sanz,et al.  Oral cyclosporine for severe vernal keratoconjunctivitis in children. , 2019, Journal francais d'ophtalmologie.

[96]  Xue-gu Xu,et al.  Therapeutic effects of Houttuynia eye drops combined with olopatadine hydrochloride eye drops on vernal keratoconjunctivitis , 2018, Experimental and therapeutic medicine.

[97]  S. Samanta,et al.  Assessment of Drug Usage Pattern in Patients Treated for Vernal Keratoconjunctivitis Attending a Tertiary Eye Care Centre in Eastern India: A Cross-Sectional Study. , 2018, Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH.

[98]  M. González-Medina,et al.  Tacrolimus as an Effective and Safe Therapeutic Alternative in Vernal Keratoconjunctivitis Resistant to Conventional Treatment. , 2018, Journal of investigational allergology & clinical immunology.

[99]  A. Lambiase,et al.  Tear Ferning Test and Pathological Effects on Ocular Surface before and after Topical Cyclosporine in Vernal Keratoconjunctivitis Patients , 2018, Journal of ophthalmology.

[100]  M. Duse,et al.  Vascular Endothelial Growth Factor (VEGF) Serological and Lacrimal Signaling in Patients Affected by Vernal Keratoconjunctivitis (VKC) , 2018, Journal of ophthalmology.

[101]  Luis Santamaría,et al.  [Long-term efficacy of omalizumab in patients with conventional treatment-resistant vernal keratoconjunctivitis]. , 2018, Revista alergia Mexico.

[102]  R. Cardona-Villa,et al.  Quality of life and clinical characterization of patients with vernal keratoconjunctivitis in a pediatric population in Colombia. , 2018, Allergologia et immunopathologia.

[103]  R. Chammas,et al.  Galectin-3: role in ocular allergy and potential as a predictive biomarker , 2018, British Journal of Ophthalmology.

[104]  H. Marey,et al.  Impact of Vernal Keratoconjunctivitis on School Children in Egypt , 2017, Seminars in ophthalmology.

[105]  Qi Wan,et al.  Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis , 2017, Ophthalmic Research.

[106]  F. Occasi,et al.  Vernal keratoconjunctivitis treated with omalizumab: A case series , 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[107]  J. A. Gomes,et al.  Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children. , 2017, Arquivos brasileiros de oftalmologia.

[108]  D. Freitas,et al.  Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial. , 2017, Arquivos brasileiros de oftalmologia.

[109]  J. A. Gomes,et al.  Supratarsal injection of triamcinolone for severe vernal keratoconjunctivitis in children. , 2017, Arquivos brasileiros de oftalmologia.

[110]  S. Yamagami,et al.  Histamine H1 and H4 receptor expression on the ocular surface of patients with chronic allergic conjunctival diseases. , 2017, Allergology international : official journal of the Japanese Society of Allergology.

[111]  E. Takamura,et al.  Japanese guidelines for allergic conjunctival diseases 2017. , 2017, Allergology international : official journal of the Japanese Society of Allergology.

[112]  B. Thong.  Allergic conjunctivitis in Asia , 2017, Asia Pacific allergy.

[113]  M. Mourits,et al.  Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops , 2017, International Ophthalmology.

[114]  J. Just,et al.  Omalizumab in Severe Refractory Vernal Keratoconjunctivitis in Children: Case Series and Review of the Literature , 2016, Ophthalmology and Therapy.

[115]  V. Sangwan,et al.  Vernal keratoconjunctivitis: culmination of management using immunosuppression, surgical and prosthetic therapy over quarter century , 2016, BMJ Case Reports.

[116]  Ozlem Eşki Yücel,et al.  Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis. , 2016, Singapore medical journal.

[117]  H. Fujishima,et al.  The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases. , 2016, The Journal of allergy and clinical immunology.

[118]  S. Esposito,et al.  An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis , 2016, Pediatric Drugs.

[119]  E. Heffler,et al.  Omalizumab Treatment of Vernal Keratoconjunctivitis. , 2016, JAMA ophthalmology.

[120]  P. Brun,et al.  Chaperone patterns in vernal keratoconjunctivitis are distinctive of cell and Hsp type and are modified by inflammatory stimuli , 2016, Allergy.

[121]  N. Gokhale.  Systematic approach to managing vernal keratoconjunctivitis in clinical practice: Severity grading system and a treatment algorithm , 2016, Indian journal of ophthalmology.

[122]  A. Al-Amri,et al.  Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis , 2016, Middle East African journal of ophthalmology.

[123]  Viney Gupta,et al.  Steroid-induced glaucoma and childhood blindness , 2015, British Journal of Ophthalmology.

[124]  V. Öner,et al.  Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety , 2012, Japanese Journal of Ophthalmology.

[125]  S. Tuft,et al.  Vernal keratoconjunctivitis in school children in Rwanda and its association with socio-economic status: a population-based survey. , 2011, The American journal of tropical medicine and hygiene.

[126]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[127]  Sunil Kumar.  Vernal keratoconjunctivitis: a major review , 2009, Acta ophthalmologica.

[128]  S. Aymé,et al.  Prevalence of vernal keratoconjunctivitis: a rare disease? , 2008, British Journal of Ophthalmology.

[129]  J. Whitcher,et al.  Pseudogerontoxon , 2004, Clinical & experimental ophthalmology.

[130]  A. Bron,et al.  Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests , 2003, Cornea.

[131]  A. Fahr.  Cyclosporin Clinical Pharmacokinetics , 1993, Clinical pharmacokinetics.

[132]  E. Takamura,et al.  Detection by Brush Cytology of Mast Cells and Eosinophils in Allergic and Vernal Conjunctivitis , 1991, Cornea.

[133]  D. Maurice,et al.  A simple conjunctival biopsy. , 1977, American journal of ophthalmology.

[134]  E. Zanin,et al.  [Omalizumab for severe vernal keratoconjunctivitis]. , 2018, Journal francais d'ophtalmologie.

[135]  D. Granet,et al.  Diagnosis and management of allergic conjunctivitis in pediatric patients. , 2017, Allergy and asthma proceedings.